SCHEMBL24930568

SCHEMBL24930568

CC(C)=C1CCCC(C)CCCCN1C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL85859 0.84 CHRM2 (0.34) —
SCHEMBL86171 0.82 CHRM2 (0.33) —
SCHEMBL18737181 0.82 CHRM2 (0.33) —
SCHEMBL18737193 0.82 CHRM2 (0.33) —
SCHEMBL18737180 0.82 CHRM2 (0.33) —
SCHEMBL86127 0.82 CHRM2 (0.35) —
SCHEMBL19806778 0.73 CHRNA7 (0.32) —
SCHEMBL15828399 0.68 — —
SCHEMBL29333661 0.67 MAPT (0.41) —
SCHEMBL19152214 0.63 MAPT (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11731956-B2 Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitors ALUMIS INC. (US) 2023-08-22 — — US disclosed
US-20230021554-A1 TYK2 INHIBITORS AND USES THEREOF ALUMIS INC. 2023-01-26 — — US disclosed
Send feedback